Xylem Inc. (NYSE:XYL) Shares Purchased by Aviva PLC

Treasurer of the State of North Carolina grew its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) by 2.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,367 shares of the biopharmaceutical company’s stock after buying an […]

Related Keywords

Thomas Tuschl ,David Bartel ,Pushkal Garg ,Akshay Vaishnaw ,Phillip Zamore ,Sumitomo Mitsui Financial Group ,Morgan Stanley ,Quarter For Alnylam Pharmaceuticals ,Exchange Commission ,Nasdaq ,Alnylam Pharmaceuticals Inc ,Alnylam Pharmaceuticals Price Performance ,Belpointe Asset Management ,Alta Advisers Ltd ,Guardian Wealth Advisors ,News Ratings For Alnylam Pharmaceuticals Daily ,Ef Hutton Acquisition Co ,Canaccord Genuity Group ,Alnylam Pharmaceuticals Profile ,Alnylam Pharmaceuticals ,Citigroup ,Ci Investments Inc ,North Carolina ,Get Rating ,Asset Management ,Wealth Advisors ,Mitsui Financial Group ,President Akshay Vaishnaw ,Noble Laureate ,Visit Holdingschannel ,Alnylam Pharmaceuticals Daily ,